Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04137289
Title A First-in-human Phase Ia/b, Open Label, Multicentre, Dose Escalation Study of BI 905711 in Patients With Advanced Gastrointestinal Cancers
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU | BEL

Facility Status City State Zip Country Details
Yale Cancer Center New Haven Connecticut 06511 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10022 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
START South Texas Accelerated Research Therapeutics, LLC San Antonio Texas 78229 United States Details
Brussels - UNIV Saint-Luc Bruxelles 1200 Belgium Details
UZ Leuven Leuven 3000 Belgium Details
Beijing Cancer Hospital Beijing 100142 China Details
The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou 510655 China Details
HOP Jean Minjoz Besançon 25030 France Details
CTR Leon Berard Lyon 69373 France Details
HOP la Milétrie Poitiers 86021 France Details
CTR Eugène Marquis Rennes 35042 France Details
Universitätsklinikum Mannheim GmbH Mannheim 68167 Germany Details
National Cancer Center Hospital East Chiba, Kashiwa 277-8577 Japan Details
Korea University Anam Hospital Seoul 02841 Korea, Republic of Details
Hospital Vall d'Hebron Barcelona 08035 Spain Details
Hospital Ramón y Cajal Madrid 28034 Spain Details
Hospital Clínico de Valencia Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field